U.S. Trauma Fixation Devices Market Analysis

U.S. Trauma Fixation Devices Market Analysis

U.S. trauma fixation devices market from internal fixators is estimated to reach over USD 2.8 billion by 2032. Increasing inclination toward internal fixators among patients can be attributed to their enhanced procedural outcomes. These devices are mainly used to stabilize fractured bones to ensure alignment by inserting them surgically.
 

Additionally, internal fixation has a myriad of benefits such as shorter hospital stays, faster physical recovery, and reduced chances of nonunion & malunion of broken bones. The U.S. reports approximately 2 million fractures each year, some of which are linked with a high risk of delayed union, non-union, and other complications associated with risk factors such as diabetes, smoking, and osteoporosis. Nearly 5%-15% of all fractures result in insufficient healing or non-union.
 

Titanium material segment held more than 35.5% share in the U.S. trauma fixation devices market in 2022. Titanium is extensively used by manufacturers to make trauma fixation devices owing to its high biocompatibility and minimal post-operative complications. It also has a lower modulus of elasticity which helps reduce the rigidity of the product and limits the amount of stress imparted on bone structures. Titanium alloys are increasingly used to fabricate orthopedic and trauma implants as they offer a high tensile strength-to-density ratio, osseointegration, corrosion resistance, and lack of toxicity.
 

U.S. trauma fixation devices market from upper extremities segment is expected to surpass USD 2.5 billion by 2032. Robust growth in the geriatric population and increasing cases of upper extremity injuries will complement the segment growth. The prevalence of sports-related injuries has increased considerably along with a notable surge in the number of patients suffering from orthopedic diseases. Furthermore, a surge in work-related upper limb disorders (WRULDs) and workplace injuries will propel the demand for trauma fixation procedures.
 

U.S. trauma fixation devices market from orthopedic centers is projected to exhibit a 3.5% CAGR from 2023-2032. A rising patient pool of bone diseases and an increasing number of orthopedic clinics will pave the way for the adoption of trauma fixation devices. Patients across developed economies such as the U.S. are heavily inclined towards orthopedic centers since they house state-of-the-art facilities that are fully equipped to cater to injury-related treatment needs of patients.

Northeast U.S. trauma fixation devices market is anticipated to record more than 3% CAGR over the forecast years 2023-2032. The Northeast zone of the U.S. has witnessed a sizeable growth in the geriatric population over the last decade resulting in higher incidences of bone diseases, such as osteoporosis and rheumatoid arthritis. New York, Maine, West Virginia, and Pennsylvania are some of the states in the Northeast part of the U.S. with a significant amount of geriatric population.